Uncategorized
Mentor Capital Seeds Glaucoma – Cannabis Venture
SAN DIEGO--(BUSINESS WIRE)--#MNTR--Mentor Capital, Inc. (MNTR) initiated funding of its GlauCanna venture that is developing medical marijuana treatment for Glaucoma patients. MNTR holds an 80% interest and Dr. Robert Mandelkorn 20%.